ArticleScientific reports2022

LncRNA MALAT1 functions as a biomarker of no-reflow phenomenon in ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention.

Xiheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.